[HTML][HTML] Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective
Neurodegenerative diseases are a group of pathological conditions that cause motor inc-
ordination (jerking movements), cognitive and memory impairments result from …
ordination (jerking movements), cognitive and memory impairments result from …
The role of altered protein acetylation in neurodegenerative disease
Acetylation is a key post-translational modification (PTM) involved in the regulation of both
histone and non-histone proteins. It controls cellular processes such as DNA transcription …
histone and non-histone proteins. It controls cellular processes such as DNA transcription …
Epigenetic changes in prion and prion-like neurodegenerative diseases: Recent advances, potential as biomarkers, and future perspectives
A Hernaiz, JM Toivonen, R Bolea… - International journal of …, 2022 - mdpi.com
Prion diseases are transmissible spongiform encephalopathies (TSEs) caused by a
conformational conversion of the native cellular prion protein (PrPC) to an abnormal …
conformational conversion of the native cellular prion protein (PrPC) to an abnormal …
Potential therapeutic role of HDAC inhibitors in FUS-ALS
C Tejido, D Pakravan, LVD Bosch - Frontiers in Molecular …, 2021 - frontiersin.org
Mutations in the FUS gene cause amyotrophic lateral sclerosis (ALS-FUS). However, the
exact pathogenic mechanism of mutant fused in sarcoma (FUS) protein is not completely …
exact pathogenic mechanism of mutant fused in sarcoma (FUS) protein is not completely …
Transactive response DNA-binding protein (TARDBP/TDP-43) regulates cell permissivity to HIV-1 infection by acting on HDAC6
R Cabrera-Rodríguez, S Pérez-Yanes… - International journal of …, 2022 - mdpi.com
The transactive response DNA-binding protein (TARDBP/TDP-43) influences the processing
of diverse transcripts, including that of histone deacetylase 6 (HDAC6). Here, we assessed …
of diverse transcripts, including that of histone deacetylase 6 (HDAC6). Here, we assessed …
Axonopathy underlying amyotrophic lateral sclerosis: Unraveling complex pathways and therapeutic insights
T Luan, Q Li, Z Huang, Y Feng, D Xu, Y Zhou, Y Hu… - Neuroscience …, 2024 - Springer
Abstract Amyotrophic Lateral Sclerosis (ALS) is a complex neurodegenerative disorder
characterized by progressive axonopathy, jointly leading to the dying back of the motor …
characterized by progressive axonopathy, jointly leading to the dying back of the motor …
Restoring Axonal Organelle Motility and Regeneration in Cultured FUS-ALS Motoneurons through Magnetic Field Stimulation Suggests an Alternative Therapeutic …
W Kandhavivorn, H Glaß, T Herrmannsdörfer… - Cells, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a devastating motoneuron disease characterized by
sustained loss of neuromuscular junctions, degenerating corticospinal motoneurons and …
sustained loss of neuromuscular junctions, degenerating corticospinal motoneurons and …
Inhibition of HDAC6 with CAY10603 alleviates acute and chronic kidney injury by suppressing the ATF6 branch of UPR
S Kan, Q Hou, R Yang, F Yang, M Zhang, Z Liu… - Archives of Biochemistry …, 2024 - Elsevier
Abstract Background Histone deacetylase 6 (HDAC6) inhibitor CAY10603 has been
identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD) …
identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD) …
A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules
KH Jensen, AK Stalder, R Wernersson… - Plos one, 2022 - journals.plos.org
Background Despite the discovery of familial cases with mutations in Cu/Zn-superoxide
dismutase (SOD1), Guanine nucleotide exchange C9orf72, TAR DNA-binding protein 43 …
dismutase (SOD1), Guanine nucleotide exchange C9orf72, TAR DNA-binding protein 43 …
[PDF][PDF] The role of altered protein acetylation in neurodegenerative
Post-translational modifications (PTMs) of proteins define the molecular complexity of our
cells. Through mechanisms such as covalent modifications of proteins, PTMs change the …
cells. Through mechanisms such as covalent modifications of proteins, PTMs change the …